1. Home
  2. ECG vs MTSR Comparison

ECG vs MTSR Comparison

Compare ECG & MTSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECG
  • MTSR
  • Stock Information
  • Founded
  • ECG 1995
  • MTSR 2022
  • Country
  • ECG United States
  • MTSR United States
  • Employees
  • ECG N/A
  • MTSR N/A
  • Industry
  • ECG
  • MTSR
  • Sector
  • ECG
  • MTSR
  • Exchange
  • ECG NYSE
  • MTSR NYSE
  • Market Cap
  • ECG 3.1B
  • MTSR 3.0B
  • IPO Year
  • ECG N/A
  • MTSR 2025
  • Fundamental
  • Price
  • ECG $64.16
  • MTSR $28.86
  • Analyst Decision
  • ECG Buy
  • MTSR Strong Buy
  • Analyst Count
  • ECG 3
  • MTSR 6
  • Target Price
  • ECG $73.00
  • MTSR $55.25
  • AVG Volume (30 Days)
  • ECG 323.4K
  • MTSR 1.1M
  • Earning Date
  • ECG 08-15-2025
  • MTSR 08-26-2025
  • Dividend Yield
  • ECG N/A
  • MTSR N/A
  • EPS Growth
  • ECG 14.34
  • MTSR N/A
  • EPS
  • ECG 2.98
  • MTSR N/A
  • Revenue
  • ECG $3,050,625,000.00
  • MTSR N/A
  • Revenue This Year
  • ECG $9.73
  • MTSR N/A
  • Revenue Next Year
  • ECG $10.17
  • MTSR N/A
  • P/E Ratio
  • ECG $21.09
  • MTSR N/A
  • Revenue Growth
  • ECG 11.77
  • MTSR N/A
  • 52 Week Low
  • ECG $31.38
  • MTSR $12.30
  • 52 Week High
  • ECG $77.93
  • MTSR $37.99
  • Technical
  • Relative Strength Index (RSI)
  • ECG N/A
  • MTSR N/A
  • Support Level
  • ECG N/A
  • MTSR N/A
  • Resistance Level
  • ECG N/A
  • MTSR N/A
  • Average True Range (ATR)
  • ECG 0.00
  • MTSR 0.00
  • MACD
  • ECG 0.00
  • MTSR 0.00
  • Stochastic Oscillator
  • ECG 0.00
  • MTSR 0.00

About ECG EVERUS CONSTRUCTION GROUP INC

Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

Share on Social Networks: